- Inicio
- Análisis de app
- Biosimilar
- Biosimilar Vs. DRUGDOCS
Biosimilar vs DRUGDOCS Uso & Estadísticas
Biologic drugs offer important treatment options for patients suffering from auto-immune disorders such as rheumatoid arthritis and for common cancers including breast and colon. Biosimilar and interchangeable products, which can loosely be thought of as ‘generic’ biologics, are important for promoting competition and driving down costs. The FDA maintains a list of approved biosimilars in the Purple Book. The Biosimilar iOS app provides a handy reference to the Purple Book as well as important information related to prescribing and dispensing for clinicians and pharmacists navigating this complex area of drug therapeutics.
** Disclaimer ** - non-medical users should ask for a doctor’s advice in addition to using this app and before making any medical decisions.
- App Store de Apple
- Pagado
- Medicina
Clasificación de tiendas
- -
DRUGDOCS® provides health professionals with current, evidence-based information on the drugs they prescribe with direct access to publications.
- App Store de Apple
- Gratis
- Medicina
Clasificación de tiendas
- -
Biosimilar frente a DRUGDOCS: comparación de la clasificación
Comparar la tendencia de clasificación de Biosimilar en los últimos 28 días con DRUGDOCS
Biosimilar#132
Rank
Comparación de las clasificaciones Biosimilar frente a DRUGDOCS por países
Comparar la tendencia de clasificación de Biosimilar en los últimos 28 días con DRUGDOCS
Todas las categorías
No hay datos disponibles
Medicina
Compara con cualquier sitio gracias a nuestra prueba gratuita
Biosimilar VS.
DRUGDOCS
19iciembre d, 2024